P. Saip Et Al. , "Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Saip, P. Et Al. 2011. Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .
Saip, P., Eralp, Y., Ozkan, M., Karaca, H., Benekli, M., Cetin, B., ... Isikdogan, A.(2011). Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
Saip, P. Et Al. "Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Saip, P. Et Al. "Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Saip, P. Et Al. (2011) . "Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
@article{article, author={P. Saip Et Al. }, title={Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}